Login / Signup

Fecal Calprotectin Assay at an Early Stage of Treatment Can Be Used as a Surrogate Marker to Predict Clinical Remission and Mucosal Healing in Pediatric Crohn's Disease.

Yeoun Joo LeeJae Hong Park
Published in: Pediatric gastroenterology, hepatology & nutrition (2022)
FC assay at an early stage of treatment can be used as a surrogate marker to predict CR and mucosal healing in pediatric CD.
Keyphrases
  • early stage
  • high throughput
  • ulcerative colitis
  • squamous cell carcinoma
  • combination therapy
  • rheumatoid arthritis
  • sentinel lymph node
  • young adults
  • systemic lupus erythematosus
  • replacement therapy
  • rectal cancer